YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Consumer confidence fell to a 12-and-a-half-year low in September as households remain concerned about labor market conditions and the Middle East crisis could continue for a longer period, which could see inflation rise further. Surging o…
[Ozempic Insulin injection pen] CR/iStock via Getty Images INVESTORS SHOULD KNOW: The obesity drug market is undergoing a structural shift, moving beyond the initial injectable GLP-1 franchise. Now, the industry is moving toward a broader…
CareDx CDNA shares ended the last trading session 13% higher at $61.37. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.6% gain over the past f…
For Immediate Release Chicago, IL – September 24, 2026 – Stocks in this week's article are CareDx CDNA, Ciena CIEN, Celestica CLS, Materion MTRN and MACOM Technology Solutions MTSI. 5 Top-Ranked High-Efficiency Stocks with Strong Profit Po…
Efficiency measures how effectively a company utilizes its resources and inputs to generate productive outputs. It is an important indicator of a company's ability to generate profits, as higher efficiency typically reflects better resourc…
Mid-cap U.S. healthcare stocks have exhibited strong momentum traits year to date, with several names earning A-range momentum grades that indicate stronger price performance trends relative to sector peers. Seeking Alpha's Quant Momentum…
Inflation climbed again in August, after easing marginally over the past two months. The latest consumer price index (CPI) print released on Friday shows that the Federal Reserve has ample reasons to go for a rate hike after its September…
The iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad sector exposure at a lower cost, while the Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) offers a concentrated, high-conviction bet on genomics. Investors seeking healthcare e…
Oil prices are on the rise once again as tensions continue to escalate in the Middle East. Markets have remained volatile for most of July and August, and the situation has worsened this month, with both the Dow and S&P 500 in the red. Inv…
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has CareDx (CDNA) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to f…
For Immediate Release Chicago, IL – August 25, 2026 – Today, Zacks Equity CareDx, Inc. CDNA, BrightSpring Health Services BTSG and PACS Group, Inc. PACS Industry: Medical Services Link: https://www.zacks.com/commentary/2978701/3-medical-se…
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
The Medical Services sector is evolving rapidly as digital health expands, value-based care gains traction, and demand for patient-centric and precision medicine solutions increases. The shift toward remote treatment is accelerating the ad…
For Immediate Release Chicago, IL – August 19, 2026 – Stocks in this week's article are CareDx CDNA, Healthcare Services Group HCSG, Forum Energy Technologies FET, Amneal Pharmaceuticals AMRX and Caterpillar CAT. 5 Top-Ranked High-Efficien…
Efficiency measures how effectively a company converts its resources and inputs into productive outputs. It is an important indicator of a company's profit-generating potential, as higher efficiency generally reflects better resource utili…
Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Discovery Fund". A copy of the letter is available to download here. Baron Discovery Fund appreciated by 19.08% (Institutional Shares) in…
3d illustration inflation and deflation graph by Deepadesigns via Shutterstock CareDx (CDNA) has surged 300% over the past year, driven by robust technical momentum and strong buy signals. CDNA is rated a "Strong Buy" by several analysts,…
[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocit…
(RTTNews) - As Warren Buffett once said, "If you find three wonderful businesses in your life, you'll get very rich." His message underscores the importance of identifying a handful of exceptional companies capable of delivering sustained…
Shares of CareDx (NASDAQ: CDNA) climbed on Friday after the precision medicine diagnostics specialist lifted its full-year sales and earnings forecast.Image source: Getty Images. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. I…
Key Points CareDx is helping to improve outcomes for transplant patients. The health monitor's non-invasive tests are in high demand.10 stocks we like better than CareDx › Shares of CareDx (NASDAQ: CDNA) climbed on Friday after the precisi…
A bank stock hits an all-time high while a medical test provider reaches a buy point of an unusual bullish chart pattern. Continue Reading
Key Points Interested in CareDx, Inc.? Here are five stocks we like better. CareDx's second-quarter revenue rose 52% to $132 million, driven by a 61% increase in testing-services revenue and a 17% rise in testing volume to 58,000 tests. Ad…
Ardent Health, Inc. (ARDT) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earni…
Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report.…
Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and materials, while weakness is more pronounced in industrials, financials, and real estate. A total of 966 companies are…
The market expects CareDx (CDNA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earni…
[Skyline of Lower Manhattan] Art Wager Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - JULY 20 * V…
CareDx CDNA shares rallied 35.6% in the last trading session to close at $40.34. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 26.7% gain…
(RTTNews) - The following biotech stocks reached 52-week highs on July 16, 2026, resulting due to anticipated quarterly report releases or an upcoming conference participation. CareDx Inc. (CDNA) CareDx is a precision medicine company spec…
(RTTNews) - Today's top gainers in the biotech space include CareDx, which rallied after Medicare finalized its Local Coverage Determination process for molecular testing of solid organ allograft rejection; AtaiBeckley, after agreeing to b…
Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52…
Cathie Wood, head of Ark Investment Management, is known for buying her favorite tech stocks during market pullbacks. That's exactly what she just did, adding shares of an AI stock after a sharp selloff. In 2025, the flagship Ark Innovatio…
CareDx CDNA recently completed the acquisition of Naveris, expanding its presence in high-growth specialty oncology. The company had announced the acquisition agreement in April as part of its strategy to strengthen its U.S. Precision Medi…
By Karen Roman CareDx, Inc. (Nasdaq: CDNA) said it completed the acquisition of Naveris, which includes its leading product, NavDx, a blood-based test for viral-mediated cancer detection including human papillomavirus, and associated head…
(RTTNews) - CareDx, Inc. (CDNA), a diagnostics company, on Wednesday announced the completion of its previously announced acquisition of Naveris, a precision oncology company, following the satisfaction of all closing conditions. In April…